Heterogeneous expression of the lipocalin NGAL in primary breast cancers.
about
A novel alternative spliced variant of neutrophil gelatinase-associated lipocalin receptor in oesophageal carcinoma cellsA proteomic analysis of human bileNFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 geneIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesNo effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancerThe endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptakeCirculating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis.GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent stateLipocalin 2 expression is associated with aggressive features of endometrial cancer.The association between the preoperative serum levels of lipocalin-2 and matrix metalloproteinase-9 (MMP-9) and prognosis of breast cancerNeutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer.MicroRNA-138 suppresses neutrophil gelatinase-associated lipocalin expression and inhibits tumorigenicity.Iron, lipocalin, and kidney epithelia.Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: effects on steroidogenesis and oncogenesis.The neglected significance of "antioxidative stress".The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancerUpregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasionLipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells.Lipocalin 2: a multifaceted modulator of human cancer.Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) StudyOverexpression of neutrophil gelatinase-associated lipocalin and its receptor in colorectal carcinoma: Significant correlation with cell differentiation and tumour invasionInterleukin-10-induced neutrophil gelatinase-associated lipocalin production in macrophages with consequences for tumor growth.DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell linesEarly diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasiaLipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progression.Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cellsLipocalin 2 promotes lung metastasis of murine breast cancer cellsCirculating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia.Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.Lipocalin 2 promotes breast cancer progressionNeutrophil gelatinase-associated lipocalin: new paths for an old shuttle.Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancerUpregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation.Neutrophil gelatinase-associated lipocalin protein as a biomarker in the diagnosis of breast cancer: A meta-analysis.Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.An early-screening biomarker of endometrial carcinoma: NGAL is associated with epithelio-mesenchymal transition.
P2860
Q24294493-BEFA2E61-0F2F-4296-A8E5-F154AD87ABA6Q28256550-83AA0775-9B34-4EB3-8A52-7CC0FEDBCC52Q28271428-412B0DAF-2B5C-4F23-92EE-AEF17F00241AQ28388335-90423034-9857-4252-8876-91948C34631CQ28480579-7CF93ADF-BCF4-4D60-86DE-7985A918D76EQ28577988-F9B214B1-4C4F-4A02-8C07-C62CA84C3BE1Q33514944-F43E6308-D1F4-44A8-961B-EF5400CBAA7CQ33688934-402365B2-E93B-43EF-874F-AE7C04D97C64Q33733727-5C86E6A0-A358-45ED-B215-A10A863B41C3Q33851325-1BFECB90-8FAE-454D-A469-02D1D6838A00Q33919758-A234F52E-AFCF-407C-901E-A125354FBBDDQ34257993-CA3284F0-8330-45D1-90AC-0F509DE6E08FQ34284339-095CCC9A-4C59-4A7B-B915-E5A74370C648Q34440998-F58FB58E-A393-490A-8F9F-23F7D6054D37Q34541482-6FDA16A6-C00F-4076-9E3C-08A1F98A9BB2Q35146299-236656F6-7B8C-49CE-91E7-75410B997A3BQ35735725-84F691DC-CF3E-43E2-8914-96AD539FD9A4Q35977855-0792ED0E-7856-4518-A1A6-C547049AF166Q35996059-A25D2120-FF67-4599-A7AE-4E5E2F087C61Q36014333-8BA07D9E-76BC-4800-ADC7-48EA6F0B4066Q36014604-1BBD102A-9DFF-4ECF-8B41-F77C8E9996ABQ36054255-E3160A4B-5BB7-442B-A526-FAEFD7F9D606Q36103565-05EA5CB6-6BCE-492C-8467-E37ACEFFC1F1Q36216274-6AF87597-B776-42B7-AF81-F45CDD72263AQ36277305-422E00A7-CBF0-47B4-BBC4-FA876BC9A1C2Q36465214-F50718B9-2B24-41E6-9152-0C94C52B479FQ36667422-186FC576-39F9-4C83-A85C-323351958D8BQ36676377-2AECDE09-BC17-401B-9311-98327334958AQ36713542-61DBC6BA-9101-43EE-B0B1-CA8DF524295CQ36893682-1A9C2B1B-977D-4660-AB7A-445638729369Q37040197-48F1D01B-0ED1-4AF2-9DBA-75D9C86CF3CCQ37100558-F116C2E7-29BC-4DEE-983A-3A20233C549BQ37117400-C5883739-7E72-4C67-84A6-D859CB9B4E6CQ37129437-D6BDCB0E-9734-4B88-ACA3-1E728F0A25B1Q37151919-2F0EECCE-040A-4823-95C0-C659080535CBQ37174014-BCB598EE-A471-40EC-85A0-A867188AA6B4Q37479941-B86FF71F-6E94-4E83-8296-E549A1757BE3Q37565348-1A92CE07-3976-48D2-B879-931DB174DE45Q37581744-C657C622-0826-4316-8A18-E4974BD881DCQ37699180-CD7B4A36-034B-4FDF-ACAE-E3E929160358
P2860
Heterogeneous expression of the lipocalin NGAL in primary breast cancers.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Heterogeneous expression of the lipocalin NGAL in primary breast cancers.
@en
Heterogeneous expression of the lipocalin NGAL in primary breast cancers.
@nl
type
label
Heterogeneous expression of the lipocalin NGAL in primary breast cancers.
@en
Heterogeneous expression of the lipocalin NGAL in primary breast cancers.
@nl
prefLabel
Heterogeneous expression of the lipocalin NGAL in primary breast cancers.
@en
Heterogeneous expression of the lipocalin NGAL in primary breast cancers.
@nl
P2093
P1476
Heterogeneous expression of the lipocalin NGAL in primary breast cancers.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.0.CO;2-F
P577
1998-12-01T00:00:00Z